Results of Single Center Study on Delcath’s PHP Therapy Published in Cancer Imaging

NEXT STORY
Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor Targeting Epigenetics in Patients with Advanced Solid Tumors
PREV STORY
Cyclacel Pharmaceuticals Announces First Patient Treated in a Phase 1/2 Study of Sapacitabine and Venetoclax in Relapsed or Refractory AML or MDS Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Terry Bradshaw Encourages Patients to “Take the Pledge to Live Well” in New PSA about Rheumatic Disease

Atlanta, Aug. 23, 2018 (GLOBE NEWSWIRE) -- This September, Sports Broadcaster Terry Bradshaw is ...

author_avatar
NASDAQ Market News

Atara Biotherapeutics Announces Appointment of Utpal Koppikar as Chief Financial Officer

SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech concludes the exploration of secondary listing to First North Sweden -not relevant at the moment

FIT Biotech Oy                                                             Company release 16.8.2018 at 4:30 PM EET FIT Biotech concludes the ...

author_avatar
NASDAQ Market News